Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a retrospective study involving all patients with a history of renal transplant that attended antenatal clinics at various Toronto hospitals and subsequently delivered between January 2000 and December 2014.
The purpose of this study is to describe the incidence of adverse pregnancy-and transplant-related outcomes, and report placental ultrasound and placental pathology findings in renal transplant recipients with contemporary standards of care in Toronto.
This study also seeks to determine whether factors such as maternal age, transplant-to-pregnancy interval, hypertension, diabetes mellitus, treatment regimens, and the primary cause for renal failure are associated with higher risk of adverse pregnancy outcomes in renal transplant recipients.
Adverse pregnancy outcomes in women with renal transplants have been attributed to a number of factors. A recent systematic review suggested an association between maternal age and adverse pregnancy outcomes such as miscarriage and stillbirth. There are also some data to suggest that maternal hypertension, diabetes mellitus, elevated serum creatinine and proteinuria and some medications such as cyclosporine are associated with adverse pregnancy outcomes such as preeclampsia, intrauterine growth restriction and preterm delivery.There is no consensus on whether the transplant-to-pregnancy interval is associated with adverse pregnancy outcomes. As well, it is not clear if the findings of other studies will also hold true in a Toronto population.
This study seeks to answer the following questions:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Maternal health outcomes obtained from patient medical record | Observed health outcomes of the mother after giving birth, obtained retrospectively from the patient's medical record. | From start of pregnancy (1 week gestation) to 6 weeks post-partum |
| Fetal and neo-natal health outcomes obtained from patient medical record | Observed health outcomes of the fetus/neonate after delivery, obtained retrospectively from the patient's medical record. | From start of pregnancy (1 week gestation) to 6 weeks post-partum |
| Placental outcomes obtained from patient medical record | Biochemistry and physical characteristics of the placenta, obtained retrospectively from the patient's medical record. | Measured immediately after delivery |
| Transplant-related outcomes obtained from patient medical record | Graft function during pregnancy and at end of pregnancy, obtained retrospectively from the patient's medical record. | From start of pregnancy (1 week gestation) to 6 weeks post-partum |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Pregnant women
Not provided
Not provided
All patients with a history of renal transplant that attended antenatal clinics at Mt. Sinai Hospital, Sunnybrook Health Sciences Centre and St.Michael's hospital and subsequently delivered between January 2000 and December 2014.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Howard Berger, MD | Unity Health Toronto | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Dec 11, 2023 | |
| Reset | Jun 6, 2024 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Dec 11, 2023 | Jun 6, 2024 |
Not provided
Not provided
Not provided